| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.685 | 9.409 | 2.009 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 5.685 | 9.409 | 2.009 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 7 | 2.922 | 2.035 | 0 | 103 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | 5.678 | 6.487 | -26 | 0 | -103 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | 5.508 | 6.295 | -87 | 0 | -103 | 0 | 0 | 0 | 0 |
| Employees | - | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Năstase Mihail Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 111 | 109 | 107 | 105 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 5.617 | 12.369 | 11.343 | 11.123 | 10.913 | 10.671 | 10.704 | 10.671 | 10.612 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.443 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 4.174 | 12.369 | 11.343 | 11.123 | 10.913 | 10.671 | 10.704 | 10.671 | 10.612 |
| Shareholders Funds | - | 5.552 | 11.753 | 11.451 | 11.229 | 10.913 | 10.671 | 10.704 | 10.671 | 10.612 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 176 | 726 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Năstase Mihail Intermed Srl